Malignant Glioma
3 competing products in clinical development for Malignant Glioma.
Pipeline by Phase
Phase 23
All Products (3)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Palonosetron (PALO) | Eisai | Phase 2 | Completed | 35 |
| Gliadel/Avastin/CPT-11 | Eisai | Phase 2 | Terminated | 27 |
| Granisetron + Ondansetron | Kyowa Kirin | Phase 2 | Withdrawn | 27 |